Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population

Digestive Diseases and Sciences

Volumn 45, Issue 6, 2000, Pages 1091-1095

  Halmos, Balazs ^a,b,c,d   Szalay, Ferenc ^a,b,c   Cserniczky, Tamas ^a,b,c   Nemesanszky, Elemer ^a,b,c   Lakatos, Peter ^a,b,c   Barlage, Stefan ^a,b,c   Schmitz, Gerd ^a,b,c   Romics, Laszlo ^a,b,c   Csaszar, Albert ^a,b,c  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b Szent Rokus Hospital   (Hungary)

^c NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Bone mineral density; Genotypes; Primary biliary cirrhosis; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; BILIARY CIRRHOSIS; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUMBAR SPINE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECEPTOR BINDING;

BONE DENSITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HUNGARY; LIVER CIRRHOSIS, BILIARY; LUMBOSACRAL REGION; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; REFERENCE VALUES;

EID: 0034085494     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005581414918     Document Type: Article

References (44)

1. 1. Morrison NA, Yeoman R, Kelly PJ, Eisman JA: Contribution of transacting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 89:6665-6669, 1992
2. 2. Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA: Genetic factors in bone turnover. J Clin Endocrinol Metab 72:808-813, 1991
3. 3. Nelson DA: The search for the osteoporosis gene. J Clin Endocrinol Metab 82:989-990, 1997
4. 4. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287, 1994
5. 5. Need AG, Horowitz M, Stiliano A, Scopacasa F, Morris HA, Chatterton BE: Vitamin D receptor genotypes are related to bone size and bone density in men. Eur J Clin Invest 26:793-796, 1996
6. 6. Spector TD, Keen RW, Arden NK, Morrison NA, Major PJ, Nguyen TV, Kelly PJ, Baker JR, Sambrook PN, Lanchbury JS, Eisman JA: Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: A twin study in Britain. BMJ 310:1357-1360, 1995
7. 7. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour J-P: Vilamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. BMJ 345:423-424, 1995
8. 8. Tokita A, Matsumoto H, Morrison NA, Tawa T, Miura Y, Fukamauchi K, Mitsuhashi N, Irimoto M, Yamamori S, Miura M, Watanabe T, Kuwabara Y, Yabuta K, Eisman JA: Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 11:1003-1009, 1996
9. 9. Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B: The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 10:985-990, 1995
10. 10. Jorgensen HL, Scholler J, Sand JC, Bjuring M, Hassager C, Christiansen C: Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: cross sectional and longitudinal population study. BMJ 313:586-590, 1996
11. 11. Gunnes M, Berg JP, Halse J, Lehmann EH: Lack of relationship between vitamin D receptor genotype and forearm bone gain in healthy children, adolescents and young adults. J Clin Endocrinol Metab 82:851-855, 1997
12. 12. Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J: Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest 94:2130-2134, 1994
13. 13. Young RP, Lau EMC, Birjandi Z, Critchley JAJII, Woo J: Interethnic differences in hip fracture rate and the vitamin D receptor polymorphism. Lancet 348:688-689, 1996
14. 14. Beavan S, Prentice A, Yan L, Dibba B, Ralston S: Differences in vitamin D receptor genotype and geographical variation in osteoporosis. Lancet 348:136-137, 1996
15. 15. Cooper G, Umbach DM: Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11:1841-1849, 1996
16. 16. Farrow S: Allelic variation and the vitamin D receptor. Lancet 343:1242, 1994
17. 17. Mundy GR: Boning up on genes. Nature 367:216-217, 1994
18. 18. van Leeuwen JPTM, Uitterlinden AG, Birkenhager JC, Pols HAP: Vitamin D receptor gene polymorphisms and osteoporosis. Steroids 61:154-156, 1996
19. 19. Dawson-Hughes B, Harris SS, Finneran S: Calcium absorption on high and low calcium intake in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80:3657-3661, 1995
20. 20. Wishart JM, Horowitz M, Need AG, Scopacasa F, Morris HA, Clifton PM, Nordin BE: Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene and calcium absorption in premenopausal women. Am J Clin Nutr 65:798-802, 1997
21. 21. Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, Kelly PJ: Genetic influences on bone density: Physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 80:2800-2805, 1995
22. 22. Park BS, Park JS, Lee DY, Youn JI, Kim IG: Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol 112:113-116, 1999
23. 23. Bellamy R, Ruwnede C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV: Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 179:721-724, 1999
24. 24. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV: Association of vitamin D receptor genotype with leprosy type. J Infect Dis 179:187-191, 1999
25. 25. Laurin JM, Lindor KD: Primary biliary cirrhosis. Dig Dis 12:331-350, 1994
26. 26. Heathcote J: Treatment of primary biliary cirrhosis. J Gastroenterol Hepatol 11:605-609, 1996
27. 27. Lindor KD: Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis. Semin Liver Dis 13:367-373, 1993
28. 28. Crippin JS, Jorgensen RA, Dickson ER, Lindor KD: Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 89:47-50, 1994
29. 29. Reichel H, Koeffler HP, Norman AW: The role of vitamin D endocrine system in health and disease. N Engl J Med 320:980-991, 1989
30. 30. Casteels K, Bouillon R, Waer M, Mathieu C: Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Curr Opin Nephrol Hypertens 4:313-318, 1995
31. 31. Manolagas SC, Yu XP, Girasole G, Bellido T: Vitamin D and the hematolymphopoietic tissue: A 1994 update. Semin Nephrol 14:129-143, 1994
32. 32. Buts JP, DcKeyser N, Collette E, Bonsignore M, Lambotte L, Desjeux JF, Sokal EM: Intestinal transport of calcium in rat biliary cirrhosis. Pediatr Res 40:533-541, 1996
33. 33. Mehal WZ, Gregory WL, Lo YM, Cross SJ, Fleming KA, Bassendine MF, James OF, Campbell RD, Chapman RW, Rosenberg WM: Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology 20:1213-1219, 1994
34. 34. Agarwal K, Jones DE, Bassendine MF: Genetic susceptibility to primary biliary cirrhosis. Eur J Gastroenterol Hepatol 11:603-606, 1999
35. 35. Mella JG, Roschmann E, Maier KP, Volk BA: Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population. Hepatology 21:398-402, 1995
36. 36. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D: Primary biliary cirrhosis shows an association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol 31:242-247, 1999
37. 37. Yu XP, Hustmyer FG, Garvey WT, Manolagas SC: Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: immunologic crossreactivity and inverse regulation with the vitamin D receptor. Proc Natl Acad Sci USA 88:8347-8351, 1991
38. 3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin I in vitro. Immunol Lett 17:361-365, 1988
39. 39. Riancho JA, Zarrabeitia MT, de Francisco AL, Amado JA, Napal J, Arias M, Gonzalez-Macias J: Vitamin D therapy modulates cytokine secretion in patients with renal failure. Nephron 65:364-368, 1993
40. 40. Clavreul A, D'hellencourt CL, Montero-Menei C, Potron G, Couez D: Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology 95:272-277, 1998
41. 3. Clin Immunol Immunopathol 53:24-31, 1989
42. 3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135:2818-2821, 1994
43. 3. Diabetologia 37:552-558, 1994
44. 44. EURODIAB Substudy 2 Study Group: Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42:51-54, 1999